Literature DB >> 21647843

MicroRNAs in the human pituitary.

Milani Sivapragasam1, Fabio Rotondo, Ricardo V Lloyd, Bernd W Scheithauer, Michael Cusimano, Luis V Syro, Kalman Kovacs.   

Abstract

MicroRNAs (miRNAs) represent a novel class of small RNA molecules that play a crucial role as post-transcriptional regulators of gene expression. As evidence for the involvement of miRNAs in various cellular processes increases, it is important to examine how miRNAs regulate gene expression. In the pituitary, aberrant miRNA expression is strongly linked with neoplasia, thus suggesting they play a role in the control of cell proliferation in adenomas. Research has built fundamental connections between aberrant miRNA expression and clinicopathological features of pituitary adenomas. Moreover, deregulated expression of miRNA target genes is often implicated in important biological pathways and thus provides significant insight into the role of miRNAs in tumorigenesis. This review will assess the significance of miRNAs in pituitary pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21647843     DOI: 10.1007/s12022-011-9167-6

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  83 in total

1.  MicroRNAs regulate pituitary development, and microRNA 26b specifically targets lymphoid enhancer factor 1 (Lef-1), which modulates pituitary transcription factor 1 (Pit-1) expression.

Authors:  Zichao Zhang; Sergio Florez; Arthur Gutierrez-Hartmann; James F Martin; Brad A Amendt
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

2.  miR-15a and miR-16-1 down-regulation in pituitary adenomas.

Authors:  Arianna Bottoni; Daniela Piccin; Federico Tagliati; Andrea Luchin; Maria Chiara Zatelli; Ettore C degli Uberti
Journal:  J Cell Physiol       Date:  2005-07       Impact factor: 6.384

3.  Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas.

Authors:  Henriett Butz; István Likó; Sándor Czirják; Péter Igaz; Mohammed Munayem Khan; Vladimir Zivkovic; Katalin Bálint; Márta Korbonits; Károly Rácz; Attila Patócs
Journal:  J Clin Endocrinol Metab       Date:  2010-07-28       Impact factor: 5.958

4.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

5.  Microtranscriptome regulation by gonadotropin-releasing hormone.

Authors:  Tony Yuen; Frederique Ruf; Tearina Chu; Stuart C Sealfon
Journal:  Mol Cell Endocrinol       Date:  2009-01-20       Impact factor: 4.102

6.  MicroRNAs differentially expressed in ACTH-secreting pituitary tumors.

Authors:  Fernando Colbari Amaral; Natalia Torres; Fabiano Saggioro; Luciano Neder; Hélio Rubens Machado; Wilson Araújo Silva; Ayrton Custódio Moreira; Margaret Castro
Journal:  J Clin Endocrinol Metab       Date:  2008-10-07       Impact factor: 5.958

Review 7.  Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update.

Authors:  Fateme Salehi; Kalman Kovacs; Bernd W Scheithauer; Ricardo V Lloyd; Michael Cusimano
Journal:  Endocr Relat Cancer       Date:  2008-09       Impact factor: 5.678

8.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

9.  High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.

Authors:  Carla Hebert; Kathleen Norris; Mark A Scheper; Nikolaos Nikitakis; John J Sauk
Journal:  Mol Cancer       Date:  2007-01-14       Impact factor: 27.401

10.  A two-stage theory of carcinogenesis in relation to the age distribution of human cancer.

Authors:  P ARMITAGE; R DOLL
Journal:  Br J Cancer       Date:  1957-06       Impact factor: 7.640

View more
  16 in total

1.  Increased miR-338-3p expression correlates with invasiveness of GH-producing pituitary adenomas.

Authors:  Yang Jong Lee; Jin Mo Cho; Ju Hyung Moon; Cheol Ryong Ku; Jean Kim; Sun Ho Kim; Eun Jig Lee
Journal:  Endocrine       Date:  2017-08-14       Impact factor: 3.633

2.  Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.

Authors:  Henriett Butz; Kinga Németh; Dóra Czenke; István Likó; Sándor Czirják; Vladimir Zivkovic; Kornélia Baghy; Márta Korbonits; Ilona Kovalszky; Péter Igaz; Károly Rácz; Attila Patócs
Journal:  Pathol Oncol Res       Date:  2016-12-21       Impact factor: 3.201

Review 3.  Epidemiology and etiopathogenesis of pituitary adenomas.

Authors:  Elena D Aflorei; Márta Korbonits
Journal:  J Neurooncol       Date:  2014-01-31       Impact factor: 4.130

Review 4.  Clinical Impact of the Current WHO Classification of Pituitary Adenomas.

Authors:  W Saeger; J Honegger; M Theodoropoulou; U J Knappe; C Schöfl; S Petersenn; R Buslei
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

Review 5.  Circulating miRNAs as biomarkers for endocrine disorders.

Authors:  H Butz; N Kinga; K Racz; A Patocs
Journal:  J Endocrinol Invest       Date:  2015-05-28       Impact factor: 4.256

Review 6.  The role of genetic and epigenetic changes in pituitary tumorigenesis.

Authors:  Hidenori Fukuoka; Yutaka Takahashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-11-29       Impact factor: 1.742

7.  Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma.

Authors:  ChuanTing Yu; JiXia Li; FengNan Sun; JinPeng Cui; HuaLi Fang; GuoLang Sui
Journal:  Med Sci Monit       Date:  2016-12-24

8.  miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ.

Authors:  Erica Gentilin; Federico Tagliati; Carlo Filieri; Daniela Molè; Mariella Minoia; Maria Rosaria Ambrosio; Ettore C Degli Uberti; Maria Chiara Zatelli
Journal:  Endocrinology       Date:  2013-03-22       Impact factor: 4.736

Review 9.  Pituitary Adenoma and the Chemokine Network: A Systemic View.

Authors:  Fabio Grizzi; Elena Monica Borroni; Alessandro Vacchini; Dorina Qehajaj; Manuela Liguori; Sanja Stifter; Maurizio Chiriva-Internati; Antonio Di Ieva
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-11       Impact factor: 5.555

Review 10.  Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System.

Authors:  Federica Barbieri; Stefano Thellung; Roberto Würth; Federico Gatto; Alessandro Corsaro; Valentina Villa; Mario Nizzari; Manuela Albertelli; Diego Ferone; Tullio Florio
Journal:  Int J Endocrinol       Date:  2014-11-17       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.